C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/04 (2006.01) A61K 31/522 (2006.01) A61P 9/00 (2006.01) C07D 473/06 (2006.01)
Patent
CA 2584904
The present invention relates to therapeutically active compounds of formula (I) which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, particularly in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
L'invention concerne des composés thérapeutiquement actifs représentés par la formule (I) qui sont des dérivés de xanthine, des procédés de production desdits dérivés, des formulations pharmaceutiques contenant les composés actifs et l'utilisation de ces composés en thérapie, notamment, pour traiter des maladies dans lesquelles la sous-activation du récepteur HM74A contribue à la maladie ou dans lesquelles l'activation dudit récepteur est bénéfique.
Hatley Richard Jonathan Daniel
Pinto Ivan Leo
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Xanthine derivatives with hm74a receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives with hm74a receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives with hm74a receptor activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732551